These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26286909)

  • 1. Cardiac devices with class 1C antiarrhythmics: a potentially toxic combination.
    Apps A; Miller CP; Fellows S; Jones M
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26286909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of acute ventricular capture threshold rise associated with flecainide acetate.
    Kang TS; Yoon YW; Park S; Hong BK; Kim D; Kwon HM; Kim HS
    Yonsei Med J; 2006 Feb; 47(1):152-4. PubMed ID: 16502500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate.
    Fornieles-Pérez H; Montoya-García M; Levine PA; Sanz O
    Pacing Clin Electrophysiol; 2002 May; 25(5):871-2. PubMed ID: 12049386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachycardia due to atrial flutter with rapid 1:1 conduction following treatment of atrial fibrillation with flecainide.
    Taylor R; Gandhi MM; Lloyd G
    BMJ; 2010 Mar; 340():b4684. PubMed ID: 20219811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion.
    Colangelo T; Johnson D; Ho R
    Tex Heart Inst J; 2021 Jun; 48(2):. PubMed ID: 34086956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical case of the month. Atrial flutter with rapid ventricular response (1:1 atrioventricular conduction) caused by flecaïnide].
    Robinet S; Melon R; Piérard L
    Rev Med Liege; 2007 Dec; 62(12):701-3. PubMed ID: 18286943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
    Van Gelder IC; Crijns HJ; Van Gilst WH; Van Wijk LM; Hamer HP; Lie KI
    Am J Cardiol; 1989 Dec; 64(19):1317-21. PubMed ID: 2511744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atrial flutter and fibrillation].
    Scharf C
    Praxis (Bern 1994); 2005 Nov; 94(45):1753-9. PubMed ID: 16320889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of cardiac arrhythmias.
    Fisch C
    Curr Probl Cardiol; 1977 Mar; 1(12):1-57. PubMed ID: 324712
    [No Abstract]   [Full Text] [Related]  

  • 12. Flecainide Toxicity Resulting in Pacemaker Latency and Intermittent Failure to Capture.
    Suffredini JM; Rutland J; Akpunonu P; Baum R; Catanzaro J; Elayi CS
    Am J Case Rep; 2019 Aug; 20():1279-1283. PubMed ID: 31467262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of cardiac arrhythmias.
    Han J
    Am Fam Physician; 1976 Jan; 13(1):128-38. PubMed ID: 1251787
    [No Abstract]   [Full Text] [Related]  

  • 14. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency treatment of tachyarrhythmias.
    Walsh KA; Ezri MD; Denes P
    Med Clin North Am; 1986 Jul; 70(4):791-811. PubMed ID: 3520184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation.
    Boriani G; Biffi M; Capucci A; Bronzetti G; Ayers GM; Zannoli R; Branzi A; Magnani B
    J Am Coll Cardiol; 1999 Feb; 33(2):333-41. PubMed ID: 9973012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation.
    Climent VE; Marin F; Mainar L; Gomez-Aldaravi R; Martinez JG; Chorro FJ; Roman P; Sogorb F
    Pacing Clin Electrophysiol; 2004 Mar; 27(3):368-72. PubMed ID: 15009866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.
    Falk RH
    Ann Intern Med; 1989 Jul; 111(2):107-11. PubMed ID: 2500880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent pacing in the absence of heart block. An approach to the management of intractable arrhythmias.
    Hornbaker JH; Humphries JO; Ross RS
    Circulation; 1969 Feb; 39(2):189-95. PubMed ID: 5766344
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of supraventricular tachycardias.
    Grogan EW; Waxman HL
    Cardiovasc Clin; 1985; 16(1):261-78. PubMed ID: 2874882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.